ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Saliva-based Screening Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-22P11399
Home | Market Reports | Business & Industrial| Business Services
Global Saliva based Screening Market Research Report 2022
BUY CHAPTERS

Global Saliva-based Screening Market Research Report 2025

Code: QYRE-Auto-22P11399
Report
March 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
Qiagen NV
Hologic Inc
Takara Bio Inc
GeneProof
Chai
Kolplast Group
Lucence Health INc
Vitagene, Inc.
ACON Laboratories Inc.
TODA PHARMA
Norgen Biotek Corp.
Kyodo International, Inc
Canvax
Zymo Research Corporation
Salimetrics
NEST Scientific USA
Miraclean Technology Co.,Ltd.
Mawi DNA Technologies
Arcis Biotechnology Limited
Abacus ALS
Therma Bright Inc
Assure Tech. (Hangzhou) Co., Ltd
Beijing Hotgen Biotech Co., Ltd
Nantong Diagnos Biotechnology Co., Ltd
NeuMoDx Molecular, Inc.
Cell Projects Ltd.

Saliva-based Screening Market Size

The global market for Saliva-based Screening was valued at US$ 396 million in the year 2024 and is projected to reach a revised size of US$ 687 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Saliva-based Screening Market

Saliva-based Screening Market

Saliva-based screening refers to a diagnostic or testing method that uses a person"s saliva (spit) as a sample to detect the presence of certain substances or conditions. This type of screening is commonly used in various fields, including healthcare, drug testing, and disease detection. Saliva-based screening offers several advantages, such as being non-invasive, easy to collect, and often more convenient than traditional blood or urine tests.
During the COVID-19 pandemic, saliva-based tests gained significant attention and adoption as an alternative to nasal swab tests. This trend was expected to continue as researchers refined and expanded saliva-based testing methods. Advances in this area were anticipated to improve test accuracy, ease of collection, and scalability.
This report aims to provide a comprehensive presentation of the global market for Saliva-based Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Saliva-based Screening.
The Saliva-based Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Saliva-based Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Saliva-based Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Saliva-based Screening Market Report

Report Metric Details
Report Name Saliva-based Screening Market
Accounted market size in year US$ 396 million
Forecasted market size in 2031 US$ 687 million
CAGR 8.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, Chai Inc., Kolplast Group, Lucence Health INc, Vitagene, Therma Bright Inc, ACON Laboratories, Inc, TODA PHARMA, Norgen Biotek Corp., Assure Tech. (Hangzhou) Co., Ltd, Beijing Hotgen Biotech Co., Ltd, Nantong Diagnos Biotechnology Co., Ltd, NeuMoDx Molecular, Inc., KYODO INTERNATIONAL INC., Canvax, Zymo Research Corporation., Salimetrics, NEST Scientific USA, Miraclean Technology Co. Ltd, Mawi DNA Technologies, Cell Projects Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Saliva-based Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Saliva-based Screening Market growing?

Ans: The Saliva-based Screening Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the Saliva-based Screening Market size in 2031?

Ans: The Saliva-based Screening Market size in 2031 will be US$ 687 million.

Who are the main players in the Saliva-based Screening Market report?

Ans: The main players in the Saliva-based Screening Market are Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, Chai Inc., Kolplast Group, Lucence Health INc, Vitagene, Therma Bright Inc, ACON Laboratories, Inc, TODA PHARMA, Norgen Biotek Corp., Assure Tech. (Hangzhou) Co., Ltd, Beijing Hotgen Biotech Co., Ltd, Nantong Diagnos Biotechnology Co., Ltd, NeuMoDx Molecular, Inc., KYODO INTERNATIONAL INC., Canvax, Zymo Research Corporation., Salimetrics, NEST Scientific USA, Miraclean Technology Co. Ltd, Mawi DNA Technologies, Cell Projects Ltd.

What are the Application segmentation covered in the Saliva-based Screening Market report?

Ans: The Applications covered in the Saliva-based Screening Market report are Diagnostic Laboratories, Hospitals & Clinics, Others

What are the Type segmentation covered in the Saliva-based Screening Market report?

Ans: The Types covered in the Saliva-based Screening Market report are Direct Sample to PCR, RT-qPCR, Lateral Flow Assays

Recommended Reports

Diagnostic Testing Markets

Saliva & Oral Testing

Rapid & Lateral Flow

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Saliva-based Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Direct Sample to PCR
1.2.3 RT-qPCR
1.2.4 Lateral Flow Assays
1.3 Market by Application
1.3.1 Global Saliva-based Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals & Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Saliva-based Screening Market Perspective (2020-2031)
2.2 Global Saliva-based Screening Growth Trends by Region
2.2.1 Global Saliva-based Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Saliva-based Screening Historic Market Size by Region (2020-2025)
2.2.3 Saliva-based Screening Forecasted Market Size by Region (2026-2031)
2.3 Saliva-based Screening Market Dynamics
2.3.1 Saliva-based Screening Industry Trends
2.3.2 Saliva-based Screening Market Drivers
2.3.3 Saliva-based Screening Market Challenges
2.3.4 Saliva-based Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Saliva-based Screening Players by Revenue
3.1.1 Global Top Saliva-based Screening Players by Revenue (2020-2025)
3.1.2 Global Saliva-based Screening Revenue Market Share by Players (2020-2025)
3.2 Global Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Saliva-based Screening Revenue
3.4 Global Saliva-based Screening Market Concentration Ratio
3.4.1 Global Saliva-based Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Saliva-based Screening Revenue in 2024
3.5 Global Key Players of Saliva-based Screening Head office and Area Served
3.6 Global Key Players of Saliva-based Screening, Product and Application
3.7 Global Key Players of Saliva-based Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Saliva-based Screening Breakdown Data by Type
4.1 Global Saliva-based Screening Historic Market Size by Type (2020-2025)
4.2 Global Saliva-based Screening Forecasted Market Size by Type (2026-2031)
5 Saliva-based Screening Breakdown Data by Application
5.1 Global Saliva-based Screening Historic Market Size by Application (2020-2025)
5.2 Global Saliva-based Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Saliva-based Screening Market Size (2020-2031)
6.2 North America Saliva-based Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Saliva-based Screening Market Size by Country (2020-2025)
6.4 North America Saliva-based Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Saliva-based Screening Market Size (2020-2031)
7.2 Europe Saliva-based Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Saliva-based Screening Market Size by Country (2020-2025)
7.4 Europe Saliva-based Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Saliva-based Screening Market Size (2020-2031)
8.2 Asia-Pacific Saliva-based Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Saliva-based Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Saliva-based Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Saliva-based Screening Market Size (2020-2031)
9.2 Latin America Saliva-based Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Saliva-based Screening Market Size by Country (2020-2025)
9.4 Latin America Saliva-based Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Saliva-based Screening Market Size (2020-2031)
10.2 Middle East & Africa Saliva-based Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Saliva-based Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Saliva-based Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher scientific
11.1.1 Thermo Fisher scientific Company Details
11.1.2 Thermo Fisher scientific Business Overview
11.1.3 Thermo Fisher scientific Saliva-based Screening Introduction
11.1.4 Thermo Fisher scientific Revenue in Saliva-based Screening Business (2020-2025)
11.1.5 Thermo Fisher scientific Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Saliva-based Screening Introduction
11.2.4 Qiagen Revenue in Saliva-based Screening Business (2020-2025)
11.2.5 Qiagen Recent Development
11.3 Hologic
11.3.1 Hologic Company Details
11.3.2 Hologic Business Overview
11.3.3 Hologic Saliva-based Screening Introduction
11.3.4 Hologic Revenue in Saliva-based Screening Business (2020-2025)
11.3.5 Hologic Recent Development
11.4 Takara Bio Inc
11.4.1 Takara Bio Inc Company Details
11.4.2 Takara Bio Inc Business Overview
11.4.3 Takara Bio Inc Saliva-based Screening Introduction
11.4.4 Takara Bio Inc Revenue in Saliva-based Screening Business (2020-2025)
11.4.5 Takara Bio Inc Recent Development
11.5 Arcis Biotechnology Limited
11.5.1 Arcis Biotechnology Limited Company Details
11.5.2 Arcis Biotechnology Limited Business Overview
11.5.3 Arcis Biotechnology Limited Saliva-based Screening Introduction
11.5.4 Arcis Biotechnology Limited Revenue in Saliva-based Screening Business (2020-2025)
11.5.5 Arcis Biotechnology Limited Recent Development
11.6 GeneProof
11.6.1 GeneProof Company Details
11.6.2 GeneProof Business Overview
11.6.3 GeneProof Saliva-based Screening Introduction
11.6.4 GeneProof Revenue in Saliva-based Screening Business (2020-2025)
11.6.5 GeneProof Recent Development
11.7 Abacus ALS
11.7.1 Abacus ALS Company Details
11.7.2 Abacus ALS Business Overview
11.7.3 Abacus ALS Saliva-based Screening Introduction
11.7.4 Abacus ALS Revenue in Saliva-based Screening Business (2020-2025)
11.7.5 Abacus ALS Recent Development
11.8 Chai Inc.
11.8.1 Chai Inc. Company Details
11.8.2 Chai Inc. Business Overview
11.8.3 Chai Inc. Saliva-based Screening Introduction
11.8.4 Chai Inc. Revenue in Saliva-based Screening Business (2020-2025)
11.8.5 Chai Inc. Recent Development
11.9 Kolplast Group
11.9.1 Kolplast Group Company Details
11.9.2 Kolplast Group Business Overview
11.9.3 Kolplast Group Saliva-based Screening Introduction
11.9.4 Kolplast Group Revenue in Saliva-based Screening Business (2020-2025)
11.9.5 Kolplast Group Recent Development
11.10 Lucence Health INc
11.10.1 Lucence Health INc Company Details
11.10.2 Lucence Health INc Business Overview
11.10.3 Lucence Health INc Saliva-based Screening Introduction
11.10.4 Lucence Health INc Revenue in Saliva-based Screening Business (2020-2025)
11.10.5 Lucence Health INc Recent Development
11.11 Vitagene
11.11.1 Vitagene Company Details
11.11.2 Vitagene Business Overview
11.11.3 Vitagene Saliva-based Screening Introduction
11.11.4 Vitagene Revenue in Saliva-based Screening Business (2020-2025)
11.11.5 Vitagene Recent Development
11.12 Therma Bright Inc
11.12.1 Therma Bright Inc Company Details
11.12.2 Therma Bright Inc Business Overview
11.12.3 Therma Bright Inc Saliva-based Screening Introduction
11.12.4 Therma Bright Inc Revenue in Saliva-based Screening Business (2020-2025)
11.12.5 Therma Bright Inc Recent Development
11.13 ACON Laboratories, Inc
11.13.1 ACON Laboratories, Inc Company Details
11.13.2 ACON Laboratories, Inc Business Overview
11.13.3 ACON Laboratories, Inc Saliva-based Screening Introduction
11.13.4 ACON Laboratories, Inc Revenue in Saliva-based Screening Business (2020-2025)
11.13.5 ACON Laboratories, Inc Recent Development
11.14 TODA PHARMA
11.14.1 TODA PHARMA Company Details
11.14.2 TODA PHARMA Business Overview
11.14.3 TODA PHARMA Saliva-based Screening Introduction
11.14.4 TODA PHARMA Revenue in Saliva-based Screening Business (2020-2025)
11.14.5 TODA PHARMA Recent Development
11.15 Norgen Biotek Corp.
11.15.1 Norgen Biotek Corp. Company Details
11.15.2 Norgen Biotek Corp. Business Overview
11.15.3 Norgen Biotek Corp. Saliva-based Screening Introduction
11.15.4 Norgen Biotek Corp. Revenue in Saliva-based Screening Business (2020-2025)
11.15.5 Norgen Biotek Corp. Recent Development
11.16 Assure Tech. (Hangzhou) Co., Ltd
11.16.1 Assure Tech. (Hangzhou) Co., Ltd Company Details
11.16.2 Assure Tech. (Hangzhou) Co., Ltd Business Overview
11.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Introduction
11.16.4 Assure Tech. (Hangzhou) Co., Ltd Revenue in Saliva-based Screening Business (2020-2025)
11.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Development
11.17 Beijing Hotgen Biotech Co., Ltd
11.17.1 Beijing Hotgen Biotech Co., Ltd Company Details
11.17.2 Beijing Hotgen Biotech Co., Ltd Business Overview
11.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Introduction
11.17.4 Beijing Hotgen Biotech Co., Ltd Revenue in Saliva-based Screening Business (2020-2025)
11.17.5 Beijing Hotgen Biotech Co., Ltd Recent Development
11.18 Nantong Diagnos Biotechnology Co., Ltd
11.18.1 Nantong Diagnos Biotechnology Co., Ltd Company Details
11.18.2 Nantong Diagnos Biotechnology Co., Ltd Business Overview
11.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Introduction
11.18.4 Nantong Diagnos Biotechnology Co., Ltd Revenue in Saliva-based Screening Business (2020-2025)
11.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Development
11.19 NeuMoDx Molecular, Inc.
11.19.1 NeuMoDx Molecular, Inc. Company Details
11.19.2 NeuMoDx Molecular, Inc. Business Overview
11.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Introduction
11.19.4 NeuMoDx Molecular, Inc. Revenue in Saliva-based Screening Business (2020-2025)
11.19.5 NeuMoDx Molecular, Inc. Recent Development
11.20 KYODO INTERNATIONAL INC.
11.20.1 KYODO INTERNATIONAL INC. Company Details
11.20.2 KYODO INTERNATIONAL INC. Business Overview
11.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Introduction
11.20.4 KYODO INTERNATIONAL INC. Revenue in Saliva-based Screening Business (2020-2025)
11.20.5 KYODO INTERNATIONAL INC. Recent Development
11.21 Canvax
11.21.1 Canvax Company Details
11.21.2 Canvax Business Overview
11.21.3 Canvax Saliva-based Screening Introduction
11.21.4 Canvax Revenue in Saliva-based Screening Business (2020-2025)
11.21.5 Canvax Recent Development
11.22 Zymo Research Corporation.
11.22.1 Zymo Research Corporation. Company Details
11.22.2 Zymo Research Corporation. Business Overview
11.22.3 Zymo Research Corporation. Saliva-based Screening Introduction
11.22.4 Zymo Research Corporation. Revenue in Saliva-based Screening Business (2020-2025)
11.22.5 Zymo Research Corporation. Recent Development
11.23 Salimetrics
11.23.1 Salimetrics Company Details
11.23.2 Salimetrics Business Overview
11.23.3 Salimetrics Saliva-based Screening Introduction
11.23.4 Salimetrics Revenue in Saliva-based Screening Business (2020-2025)
11.23.5 Salimetrics Recent Development
11.24 NEST Scientific USA
11.24.1 NEST Scientific USA Company Details
11.24.2 NEST Scientific USA Business Overview
11.24.3 NEST Scientific USA Saliva-based Screening Introduction
11.24.4 NEST Scientific USA Revenue in Saliva-based Screening Business (2020-2025)
11.24.5 NEST Scientific USA Recent Development
11.25 Miraclean Technology Co. Ltd
11.25.1 Miraclean Technology Co. Ltd Company Details
11.25.2 Miraclean Technology Co. Ltd Business Overview
11.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Introduction
11.25.4 Miraclean Technology Co. Ltd Revenue in Saliva-based Screening Business (2020-2025)
11.25.5 Miraclean Technology Co. Ltd Recent Development
11.26 Mawi DNA Technologies
11.26.1 Mawi DNA Technologies Company Details
11.26.2 Mawi DNA Technologies Business Overview
11.26.3 Mawi DNA Technologies Saliva-based Screening Introduction
11.26.4 Mawi DNA Technologies Revenue in Saliva-based Screening Business (2020-2025)
11.26.5 Mawi DNA Technologies Recent Development
11.27 Cell Projects Ltd.
11.27.1 Cell Projects Ltd. Company Details
11.27.2 Cell Projects Ltd. Business Overview
11.27.3 Cell Projects Ltd. Saliva-based Screening Introduction
11.27.4 Cell Projects Ltd. Revenue in Saliva-based Screening Business (2020-2025)
11.27.5 Cell Projects Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Thermo Fisher Scientific
Qiagen NV
Hologic Inc
Takara Bio Inc
GeneProof
Chai
Kolplast Group
Lucence Health INc
Vitagene, Inc.
ACON Laboratories Inc.
TODA PHARMA
Norgen Biotek Corp.
Kyodo International, Inc
Canvax
Zymo Research Corporation
Salimetrics
NEST Scientific USA
Miraclean Technology Co.,Ltd.
Mawi DNA Technologies
Arcis Biotechnology Limited
Abacus ALS
Therma Bright Inc
Assure Tech. (Hangzhou) Co., Ltd
Beijing Hotgen Biotech Co., Ltd
Nantong Diagnos Biotechnology Co., Ltd
NeuMoDx Molecular, Inc.
Cell Projects Ltd.
List of Tables
 Table 1. Global Saliva-based Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Direct Sample to PCR
 Table 3. Key Players of RT-qPCR
 Table 4. Key Players of Lateral Flow Assays
 Table 5. Global Saliva-based Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Saliva-based Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Saliva-based Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Saliva-based Screening Market Share by Region (2020-2025)
 Table 9. Global Saliva-based Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Saliva-based Screening Market Share by Region (2026-2031)
 Table 11. Saliva-based Screening Market Trends
 Table 12. Saliva-based Screening Market Drivers
 Table 13. Saliva-based Screening Market Challenges
 Table 14. Saliva-based Screening Market Restraints
 Table 15. Global Saliva-based Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Saliva-based Screening Market Share by Players (2020-2025)
 Table 17. Global Top Saliva-based Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saliva-based Screening as of 2024)
 Table 18. Ranking of Global Top Saliva-based Screening Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Saliva-based Screening Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Saliva-based Screening, Headquarters and Area Served
 Table 21. Global Key Players of Saliva-based Screening, Product and Application
 Table 22. Global Key Players of Saliva-based Screening, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Saliva-based Screening Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Saliva-based Screening Revenue Market Share by Type (2020-2025)
 Table 26. Global Saliva-based Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Saliva-based Screening Revenue Market Share by Type (2026-2031)
 Table 28. Global Saliva-based Screening Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Saliva-based Screening Revenue Market Share by Application (2020-2025)
 Table 30. Global Saliva-based Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Saliva-based Screening Revenue Market Share by Application (2026-2031)
 Table 32. North America Saliva-based Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Saliva-based Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Saliva-based Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Saliva-based Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Saliva-based Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Saliva-based Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Saliva-based Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Saliva-based Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Saliva-based Screening Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Saliva-based Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Saliva-based Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Saliva-based Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Saliva-based Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Saliva-based Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Saliva-based Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Thermo Fisher scientific Company Details
 Table 48. Thermo Fisher scientific Business Overview
 Table 49. Thermo Fisher scientific Saliva-based Screening Product
 Table 50. Thermo Fisher scientific Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 51. Thermo Fisher scientific Recent Development
 Table 52. Qiagen Company Details
 Table 53. Qiagen Business Overview
 Table 54. Qiagen Saliva-based Screening Product
 Table 55. Qiagen Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 56. Qiagen Recent Development
 Table 57. Hologic Company Details
 Table 58. Hologic Business Overview
 Table 59. Hologic Saliva-based Screening Product
 Table 60. Hologic Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 61. Hologic Recent Development
 Table 62. Takara Bio Inc Company Details
 Table 63. Takara Bio Inc Business Overview
 Table 64. Takara Bio Inc Saliva-based Screening Product
 Table 65. Takara Bio Inc Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 66. Takara Bio Inc Recent Development
 Table 67. Arcis Biotechnology Limited Company Details
 Table 68. Arcis Biotechnology Limited Business Overview
 Table 69. Arcis Biotechnology Limited Saliva-based Screening Product
 Table 70. Arcis Biotechnology Limited Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 71. Arcis Biotechnology Limited Recent Development
 Table 72. GeneProof Company Details
 Table 73. GeneProof Business Overview
 Table 74. GeneProof Saliva-based Screening Product
 Table 75. GeneProof Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 76. GeneProof Recent Development
 Table 77. Abacus ALS Company Details
 Table 78. Abacus ALS Business Overview
 Table 79. Abacus ALS Saliva-based Screening Product
 Table 80. Abacus ALS Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 81. Abacus ALS Recent Development
 Table 82. Chai Inc. Company Details
 Table 83. Chai Inc. Business Overview
 Table 84. Chai Inc. Saliva-based Screening Product
 Table 85. Chai Inc. Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 86. Chai Inc. Recent Development
 Table 87. Kolplast Group Company Details
 Table 88. Kolplast Group Business Overview
 Table 89. Kolplast Group Saliva-based Screening Product
 Table 90. Kolplast Group Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 91. Kolplast Group Recent Development
 Table 92. Lucence Health INc Company Details
 Table 93. Lucence Health INc Business Overview
 Table 94. Lucence Health INc Saliva-based Screening Product
 Table 95. Lucence Health INc Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 96. Lucence Health INc Recent Development
 Table 97. Vitagene Company Details
 Table 98. Vitagene Business Overview
 Table 99. Vitagene Saliva-based Screening Product
 Table 100. Vitagene Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 101. Vitagene Recent Development
 Table 102. Therma Bright Inc Company Details
 Table 103. Therma Bright Inc Business Overview
 Table 104. Therma Bright Inc Saliva-based Screening Product
 Table 105. Therma Bright Inc Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 106. Therma Bright Inc Recent Development
 Table 107. ACON Laboratories, Inc Company Details
 Table 108. ACON Laboratories, Inc Business Overview
 Table 109. ACON Laboratories, Inc Saliva-based Screening Product
 Table 110. ACON Laboratories, Inc Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 111. ACON Laboratories, Inc Recent Development
 Table 112. TODA PHARMA Company Details
 Table 113. TODA PHARMA Business Overview
 Table 114. TODA PHARMA Saliva-based Screening Product
 Table 115. TODA PHARMA Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 116. TODA PHARMA Recent Development
 Table 117. Norgen Biotek Corp. Company Details
 Table 118. Norgen Biotek Corp. Business Overview
 Table 119. Norgen Biotek Corp. Saliva-based Screening Product
 Table 120. Norgen Biotek Corp. Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 121. Norgen Biotek Corp. Recent Development
 Table 122. Assure Tech. (Hangzhou) Co., Ltd Company Details
 Table 123. Assure Tech. (Hangzhou) Co., Ltd Business Overview
 Table 124. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product
 Table 125. Assure Tech. (Hangzhou) Co., Ltd Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 126. Assure Tech. (Hangzhou) Co., Ltd Recent Development
 Table 127. Beijing Hotgen Biotech Co., Ltd Company Details
 Table 128. Beijing Hotgen Biotech Co., Ltd Business Overview
 Table 129. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product
 Table 130. Beijing Hotgen Biotech Co., Ltd Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 131. Beijing Hotgen Biotech Co., Ltd Recent Development
 Table 132. Nantong Diagnos Biotechnology Co., Ltd Company Details
 Table 133. Nantong Diagnos Biotechnology Co., Ltd Business Overview
 Table 134. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product
 Table 135. Nantong Diagnos Biotechnology Co., Ltd Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 136. Nantong Diagnos Biotechnology Co., Ltd Recent Development
 Table 137. NeuMoDx Molecular, Inc. Company Details
 Table 138. NeuMoDx Molecular, Inc. Business Overview
 Table 139. NeuMoDx Molecular, Inc. Saliva-based Screening Product
 Table 140. NeuMoDx Molecular, Inc. Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 141. NeuMoDx Molecular, Inc. Recent Development
 Table 142. KYODO INTERNATIONAL INC. Company Details
 Table 143. KYODO INTERNATIONAL INC. Business Overview
 Table 144. KYODO INTERNATIONAL INC. Saliva-based Screening Product
 Table 145. KYODO INTERNATIONAL INC. Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 146. KYODO INTERNATIONAL INC. Recent Development
 Table 147. Canvax Company Details
 Table 148. Canvax Business Overview
 Table 149. Canvax Saliva-based Screening Product
 Table 150. Canvax Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 151. Canvax Recent Development
 Table 152. Zymo Research Corporation. Company Details
 Table 153. Zymo Research Corporation. Business Overview
 Table 154. Zymo Research Corporation. Saliva-based Screening Product
 Table 155. Zymo Research Corporation. Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 156. Zymo Research Corporation. Recent Development
 Table 157. Salimetrics Company Details
 Table 158. Salimetrics Business Overview
 Table 159. Salimetrics Saliva-based Screening Product
 Table 160. Salimetrics Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 161. Salimetrics Recent Development
 Table 162. NEST Scientific USA Company Details
 Table 163. NEST Scientific USA Business Overview
 Table 164. NEST Scientific USA Saliva-based Screening Product
 Table 165. NEST Scientific USA Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 166. NEST Scientific USA Recent Development
 Table 167. Miraclean Technology Co. Ltd Company Details
 Table 168. Miraclean Technology Co. Ltd Business Overview
 Table 169. Miraclean Technology Co. Ltd Saliva-based Screening Product
 Table 170. Miraclean Technology Co. Ltd Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 171. Miraclean Technology Co. Ltd Recent Development
 Table 172. Mawi DNA Technologies Company Details
 Table 173. Mawi DNA Technologies Business Overview
 Table 174. Mawi DNA Technologies Saliva-based Screening Product
 Table 175. Mawi DNA Technologies Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 176. Mawi DNA Technologies Recent Development
 Table 177. Cell Projects Ltd. Company Details
 Table 178. Cell Projects Ltd. Business Overview
 Table 179. Cell Projects Ltd. Saliva-based Screening Product
 Table 180. Cell Projects Ltd. Revenue in Saliva-based Screening Business (2020-2025) & (US$ Million)
 Table 181. Cell Projects Ltd. Recent Development
 Table 182. Research Programs/Design for This Report
 Table 183. Key Data Information from Secondary Sources
 Table 184. Key Data Information from Primary Sources
 Table 185. Authors List of This Report


List of Figures
 Figure 1. Saliva-based Screening Picture
 Figure 2. Global Saliva-based Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Saliva-based Screening Market Share by Type: 2024 VS 2031
 Figure 4. Direct Sample to PCR Features
 Figure 5. RT-qPCR Features
 Figure 6. Lateral Flow Assays Features
 Figure 7. Global Saliva-based Screening Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Saliva-based Screening Market Share by Application: 2024 VS 2031
 Figure 9. Diagnostic Laboratories Case Studies
 Figure 10. Hospitals & Clinics Case Studies
 Figure 11. Others Case Studies
 Figure 12. Saliva-based Screening Report Years Considered
 Figure 13. Global Saliva-based Screening Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Saliva-based Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Saliva-based Screening Market Share by Region: 2024 VS 2031
 Figure 16. Global Saliva-based Screening Market Share by Players in 2024
 Figure 17. Global Top Saliva-based Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Saliva-based Screening as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Saliva-based Screening Revenue in 2024
 Figure 19. North America Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Saliva-based Screening Market Share by Country (2020-2031)
 Figure 21. United States Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Saliva-based Screening Market Share by Country (2020-2031)
 Figure 25. Germany Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Saliva-based Screening Market Share by Region (2020-2031)
 Figure 33. China Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Saliva-based Screening Market Share by Country (2020-2031)
 Figure 41. Mexico Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Saliva-based Screening Market Share by Country (2020-2031)
 Figure 45. Turkey Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Saliva-based Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Thermo Fisher scientific Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 49. Qiagen Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 50. Hologic Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 51. Takara Bio Inc Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 52. Arcis Biotechnology Limited Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 53. GeneProof Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 54. Abacus ALS Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 55. Chai Inc. Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 56. Kolplast Group Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 57. Lucence Health INc Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 58. Vitagene Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 59. Therma Bright Inc Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 60. ACON Laboratories, Inc Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 61. TODA PHARMA Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 62. Norgen Biotek Corp. Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 63. Assure Tech. (Hangzhou) Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 64. Beijing Hotgen Biotech Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 65. Nantong Diagnos Biotechnology Co., Ltd Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 66. NeuMoDx Molecular, Inc. Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 67. KYODO INTERNATIONAL INC. Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 68. Canvax Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 69. Zymo Research Corporation. Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 70. Salimetrics Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 71. NEST Scientific USA Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 72. Miraclean Technology Co. Ltd Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 73. Mawi DNA Technologies Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 74. Cell Projects Ltd. Revenue Growth Rate in Saliva-based Screening Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Saliva Drug and Alcohol Testing Market Research Report 2024
Global Panel Saliva Test Kits Market Research Report 2024
Saliva Collection and Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Saliva Virus Detection Kit Market Research Report 2024
Global Oral Fluid Drug Testing Kit Market Insights Forecast to 2030
Global Oral Fluid Swab Drug Tests Market Research Report 2024
Oral Fluid Collection System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Salivary Drug Testing Reagents and Equipment Market Research Report 2024
Global Oral Fluid Collection Devices Market Insights Forecast to 2030
Global Saliva Based Home Test Kits Market Research Report 2024
Global Rapid Saliva Testing Devices Market Research Report 2024
Global Instant Saliva Testing Devices Market Insights Forecast to 2030
Global Rapid Oral Fluid Screening Devices Market Research Report 2024
Global Saliva Collection Devices Market Research Report 2024
Global Oral Fluid Collection Tubes for Workplace Testing Market Insights Forecast to 2030
Global Oral Fluid Collection Tubes for Disease Testing Market Insights Forecast to 2030
Global Oral Fluid Drug Testing Reagents Market Research Report 2024
Global Drug of Abuse Test Saliva Device Market Research Report 2025
Global Oral Fluid Collection Tubes Market Insights Forecast to 2030
Global General Oral Fluid Collection Device Market Insights Forecast to 2030

RELATED REPORTS

Global BPO in Public Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17F6185
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ultra-Thin Thermal Management Transfer Tape Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15E19879
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stencil Printer for Semiconductor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29C17006
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gamification in Sports Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4X18374
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions